Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 35 full-time employees. The company went IPO on 2016-06-03. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.
Follow-Up Questions
Sensus Healthcare Inc (SRTS) 的市盈率是多少?
Sensus Healthcare Inc 的市盈率是 7.7538
Sensus Healthcare Inc 的 CEO 是谁?
Mr. Joseph Sardano 是 Sensus Healthcare Inc 的 Chairman of the Board,自 2010 加入公司。
SRTS 股票的价格表现如何?
SRTS 的当前价格为 $3.11,在上个交易日 increased 了 0.03%。
Sensus Healthcare Inc 的主要业务主题或行业是什么?
Sensus Healthcare Inc 属于 Health Care 行业,该板块是 Health Care